Trial 9L-11-2

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Deferasirox in Patients with Myelodysplastic Syndromes (Low/Int-1 Risk) and Transfusional Iron Overload (TELESTO).

Type: Cancer Therapy
Phase: Phase III
Status: Open to Accrual
Treatments: Other
Randomized: Yes
Defintions of terms and FAQ about clinical trials.

Trial Leaders/Researchers: Vinod Pullarkat, M.D.
Other Trial Staff: Lori Vergara, R.N., Ibrahim Syed, D.M.

Staff may log in to see study documents.

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.